Cerus (CERS) Income from Non-Controlling Interests (2022 - 2026)
Cerus' (CERS) quarterly Income from Non-Controlling Interests came in at -$42000.0 in Q2 2026, down 425.0% year-over-year from $12923.1 in Q2 2025, and down 425.0% quarter-over-quarter from -$8000.0 in Q1 2026.
Powered by 
Analysis
Cerus (CERS) Income from Non-Controlling Interests (2022 - 2026) Analysis & Trends
Cerus has disclosed Income from Non-Controlling Interests across 3 years of filings, most recently posting -$42000.0 for Q2 2026.
- In Q2 2026, Income from Non-Controlling Interests fell 425.0% year-over-year to -$42000.0; the TTM figure through Jun 2026 stood at -$59000.0 (down 9.26% YoY), while the FY2021 annual figure was $460000.0, down 52.97% from the prior year.
- Income from Non-Controlling Interests came in at -$42000.0 for Q2 2026 at Cerus, down from -$8000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of -$1000.0 in Q1 2025 to a low of -$42000.0 in Q2 2026.
- Average Income from Non-Controlling Interests over 3 years is -$17333.3, with a median of -$8000.0 recorded in 2025.
- The largest YoY upside for Income from Non-Controlling Interests was 425.0% in 2026 against a maximum downside of 700.0% in 2026.
- Over 3 years, Income from Non-Controlling Interests stood at -$39000.0 in 2022, then soared by 79.49% to -$8000.0 in 2025, then slumped by 425.0% to -$42000.0 in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were -$42000.0 in Q2 2026, -$8000.0 in Q1 2026, and -$8000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 900,000.00 |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn | -42,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -42,000.00 |
| Mar 31, 2026 | -8,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Sep 30, 2022 | -39,000.00 |
| Jun 30, 2022 | -6,000.00 |